Show items per page
Elements: 7
Page 1 on 1
 TitleAuthors / EditorsDate
add to browser selection
A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives Morbelli, Silvia; Garibotto, Valentina; Van De Giessen, Elsmarieke; Arbizu, Javier; ... Pagani, Marco 2015
add to browser selection
Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI) Nathan, Pradeep J; Lim, Yen Ying; Abbott, Rosemary; Galluzzi, Samantha; ... Frisoni, Giovanni 2017
add to browser selection
Plasma Aβ42 as Biomarker of Prodromal Alzheimer's Disease Progression in Patients with Amnestic Mild Cognitive Impairment: Evidence from the PharmaCog/E-ADNI Study Albani, Diego; Marizzoni, Moira; Ferrari, Clarissa; Fusco, Federica; ... Frisoni, Giovanni 2018
add to browser selection
Biomarker Matrix to Track Short Term Disease Progression in Amnestic Mild Cognitive Impairment Patients with Prodromal Alzheimer's Disease Marizzoni, Moira; Ferrari, Clarissa; Macis, Ambra; Jovicich, Jorge; ... Frisoni, Giovanni 2019
add to browser selection
Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study Lopes Alves, Isadora; Collij, Lyduine E; Altomare, Daniele; Frisoni, Giovanni; ... Molinuevo, José Luis 2020
add to browser selection
Amygdalar nuclei and hippocampal subfields on MRI: Test-retest reliability of automated volumetry across different MRI sites and vendors Quattrini, Giulia; Pievani, Michela; Jovicich, Jorge; Aiello, Marco; ... Marizzoni, Moira 2020
add to browser selection
CSF cutoffs for MCI due to AD depend on APOEε4 carrier status Marizzoni, Moira; Ferrari, Clarissa; Babiloni, Claudio; Albani, Diego; ... Frisoni, Giovanni 2020